Olivo, L.B.; de Oliveira Henz, P.; Wermann, S.; Dias, B.B.; Porto, G.O.; Pinhatti, A.V.; Martins, M.D.; Gregianin, L.J.; Costa, T.D.; de Araújo, B.V.
Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model. Pharmaceutics 2024, 16, 1180.
https://doi.org/10.3390/pharmaceutics16091180
AMA Style
Olivo LB, de Oliveira Henz P, Wermann S, Dias BB, Porto GO, Pinhatti AV, Martins MD, Gregianin LJ, Costa TD, de Araújo BV.
Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model. Pharmaceutics. 2024; 16(9):1180.
https://doi.org/10.3390/pharmaceutics16091180
Chicago/Turabian Style
Olivo, Laura Ben, Pricilla de Oliveira Henz, Sophia Wermann, Bruna Bernar Dias, Gabriel Osorio Porto, Amanda Valle Pinhatti, Manoela Domingues Martins, Lauro José Gregianin, Teresa Dalla Costa, and Bibiana Verlindo de Araújo.
2024. "Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model" Pharmaceutics 16, no. 9: 1180.
https://doi.org/10.3390/pharmaceutics16091180
APA Style
Olivo, L. B., de Oliveira Henz, P., Wermann, S., Dias, B. B., Porto, G. O., Pinhatti, A. V., Martins, M. D., Gregianin, L. J., Costa, T. D., & de Araújo, B. V.
(2024). Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model. Pharmaceutics, 16(9), 1180.
https://doi.org/10.3390/pharmaceutics16091180